Found: 8
Select item for more details and to access through your institution.
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.701345
- By:
- Publication type:
- Article
Detection of Microsatellite Instability via Circulating Tumor DNA and Response to Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: A Case Series.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 190, doi. 10.1159/000512819
- By:
- Publication type:
- Article
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1072, doi. 10.1093/oncolo/oyad154
- By:
- Publication type:
- Article
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 239, doi. 10.1093/oncolo/oyac236
- By:
- Publication type:
- Article
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1017, doi. 10.1002/onco.13922
- By:
- Publication type:
- Article
Clinical Outcomes and Racial Disparities in Metastatic Hormone‐Sensitive Prostate Cancer in the Era of Novel Treatment Options.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 956, doi. 10.1002/onco.13848
- By:
- Publication type:
- Article
Immune‐Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1742, doi. 10.1002/onco.13868
- By:
- Publication type:
- Article
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 397, doi. 10.1002/onco.13727
- By:
- Publication type:
- Article